Home
Explore
Library
Apple Hit with Rare Sell Rating, J&J's Ketamine-Derived Nasal Spray Gets FDA Approved for Depression - The Rundown - Podfriend
January 21, 2025
Apple Hit with Rare Sell Rating, J&J's Ketamine-Derived Nasal Spray Gets FDA Approved for Depression
The Rundown
8m
About this episode
Stock market update for January 21, 2025. Check out our Instagram account @TheRundownDaily
Episode Webpage →